AMARIN's VASCEPA patent loss: is it obvious(ness)?

05/07/20 • 11 min

Patent management is the hot topic of this episode. The focus is on AMARIN’s leading product, VASCEPA, a drug made up of natural derivatives such as fish oil and was approved by the FDA in December 2019.

Healthcare consultant Jared Wolff is joined by Bruna Favetta who has experience with the development of patent strategy, and Kate Jones who has a background in law.

AMARIN has recently found themselves in unchartered territory as VASCEPA’s drug patent is being challenged by generic producers, this episode explores:

Why this case of VASCEPA is significant
How this may set a future precedent in drug patent law

Thanks for listening!

Healthcare consultant Jared Wolff is joined by Bruna Favetta who has experience with the development of patent strategy, and Kate Jones who has a background in law.

AMARIN has recently found themselves in unchartered territory as VASCEPA’s drug patent is being challenged by generic producers, this episode explores:

Why this case of VASCEPA is significant
How this may set a future precedent in drug patent law

Thanks for listening!

Previous Episode

COVID-19 (Pt 2): Promising Treatments in Development

In Part 2 of the COVID-19 series, healthcare consultant Jared Wolff is again joined by Matthew Rube and Akhil Parlapalli from CBPartners’ New York office to discuss some of the most promising treatments that are currently being put to the test against COVID-19. These include:

REMDESIVIR, Gilead
Hydroxychloroquine + azithromycin (Z-Pak), Pfizer
·A more novel approach by Distributed Bio

Next Episode

COVID-19 (Pt 3): Testing

This final episode of the COVID-19 trilogy focuses on testing. Specifically, the different types of tests available for COVID-19 and the regulatory environment in which these tests exist. How will an accurate test change how healthcare experts respond to the disease? Healthcare consultant Jared Wolff is joined by the COVID-19 Podcast Team, Matthew Rube and Akhil Parlapalli, to discuss themes about:

Testing Basics
Regulatory Environment and Implications
Big Pharma Moves and Updated for Treatment, Vaccines, and Testing

We would like to extend a thank you to Dr. Melodie Feather, who recommended the topic of testing to us as one we should cover. We appreciate your input, and look forward to receiving ideas from more listeners.

We hope you enjoy the content and thanks for listening!